Platelet Glycoprotein GPIIb-IIIa Complex Concept

subject area of

• A Barbourin-albumin Fusion Protein that Is Slowly Cleared In Vivo Retains the Ability to Inhibit Platelet Aggregation In Vitro  Academic Article
• A simple and rapid competitive enzyme-linked immunosorbent assay to identify HPA-1a (PlA1)-negative donor platelet units  Academic Article
• ABH antigens on human platelets: Expression on the glycosyl phosphatidylinositol-anchored protein CD109  Academic Article
• Activated Clotting Time to Guide Heparin Dosing in Non–ST-Segment–Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors  Academic Article
• Analyses of cellular multimerin 1 receptors: in vitro evidence of binding mediated by αΙΙbβ3 and αvβ3  Academic Article
• Angina (unstable).  Academic Article
• Angina (unstable).  Academic Article
• Angina (unstable).  Academic Article
• Anticoagulation With Otamixaban and Ischemic Events in Non–ST-Segment Elevation Acute Coronary Syndromes  Academic Article
• Antiplatelet Drugs  Academic Article
• Antiplatelet Drugs  Academic Article
• Antiplatelet drugs  Academic Article
• Antithrombotic Therapy in Patients Undergoing Coronary Angioplasty  Academic Article
• Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention  Academic Article
• Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines.  Academic Article
• Beyond Heparin and Aspirin  Academic Article
• Bivalirudin  Academic Article
• Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa (αIIb/β3) receptor-directed platelet inhibition  Academic Article
• Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition  Academic Article
• Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial)  Academic Article
• Comparison of degree of platelet inhibition by abciximab versus tirofiban in patients with unstable angina pectoris and non–Q-wave myocardial infarction undergoing percutaneous coronary intervention  Academic Article
• Comparison of the effect of coagulation and platelet function impairments on various mouse bleeding models  Academic Article
• Dark Chocolate Effect on Platelet Activity, C-Reactive Protein and Lipid Profile: A Pilot Study  Academic Article
• Decreasing Mortality With Primary Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction: The Mayo Clinic Experience From 1991 Through 1997  Conference Paper
• Drug-Induced Immune-Mediated Thrombocytopenia — From Purpura to Thrombosis  Academic Article
• Economic issues in glycoprotein IIb/IIIa receptor therapy  Academic Article
• Effect of abciximab on late adverse events in patients with diabetes mellitus undergoing stent implantation  Academic Article
• Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Treated With Glycoprotein IIb/IIIa Inhibitors or Thienopyridines  Academic Article
• Efficacy and safety of a routine early invasive strategy after fibrinolysis stratified by glycoprotein IIb/IIIa inhibitor use during percutaneous coronary intervention: a pre-specified subgroup analysis of the TRANSFER-AMI randomised controlled trial  Academic Article
• Efficacy and safety of clopidogrel pretreatment before percutaneous coronary intervention with and without glycoprotein IIb/IIIa inhibitor use  Academic Article
• Ethanol enhances the inhibitory effect of an oral GPIIb/IIIa antagonist on human platelet function  Academic Article
• Evaluation of the role of abciximab (Reopro) as a rescue agent during percutaneous coronary interventions: In-hospital and six-month outcomes  Academic Article
• From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes The Global Registry of Acute Coronary Events (GRACE)  Academic Article
• Glycoprotein IIb/IIIa Receptor Therapy in Percutaneous Coronary Intervention and Non???ST-Segment Elevation Acute Coronary Syndromes  Academic Article
• HUMAN PLATELET THROMBIN RECEPTORS  Academic Article
• IIb or not IIb: When, how, and which GP IIb/IIIa inhibitor?  Academic Article
• Inhibition of Microsurgical Thrombosis by the Platelet Glycoprotein IIb/IIIa Antagonist SR121566A  Academic Article
• Inhibition of platelet-dependent prothrombinase activity and thrombin generation by glycoprotein IIb/IIIa receptor-directed antagonists: potential contributing mechanism of benefit in acute coronary syndromes.  Academic Article
• Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial Infarction  Academic Article
• Management strategies in unstable coronary artery disease-Current problems and future directions  Academic Article
• New Antithrombotic Agents  Academic Article
• Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial  Academic Article
• Performance characteristics of platelet autoantibody testing for the diagnosis of immune thrombocytopenia using strict clinical criteria  Academic Article
• Platelet activation induced by porcine factor VIII (HYATE:C)  Academic Article
• Platelet-Active Drugs  Academic Article
• Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects  Academic Article
• Platelet-active drugs : the relationships among dose, effectiveness, and side effects.  Academic Article
• Platelet-active drugs: the relationships among dose, effectiveness, and side effects.  Academic Article
• Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration  Academic Article
• Preventing thrombosis: update of first-line therapy in the management of non-ST segment elevation acute coronary syndromes.  Academic Article
• Radial versus femoral access for emergent percutaneous coronary intervention with adjunct glycoprotein IIb/IIIa inhibition in acute myocardial infarction—the RADIAL-AMI pilot randomized trial  Academic Article
• Recombinant albumins containing additional peptide sequences smaller than barbourin retain the ability of barbourin-albumin to inhibit platelet aggregation  Academic Article
• Recommendations for the implementation of platelet autoantibody testing in clinical trials of immune thrombocytopenia  Academic Article
• Routine vs Selective Invasive Strategies in Acute Coronary Syndromes  Academic Article
• Stenting and glycoprotein IIb/IIIa inhibition in patients with acute myocardial infarction undergoing percutaneous coronary intervention: Findings from the global registry of acute coronary events (GRACE)  Academic Article
• The Editor's Roundtable: Arterial Thrombosis and Acute Coronary Syndromes  Academic Article
• The IgG subclasses of platelet-associated autoantibodies directed against platelet glycoproteins IIb/IIIa in patients with idiopathic thrombocytopenic purpura  Academic Article
• The effect of rituximab on anti‐platelet autoantibody levels in patients with immune thrombocytopenia  Academic Article
• The platelet cytoskeleton stabilizes the interaction between αIIbβ3 and its ligand and induces selective movements of ligand-occupied integrin  Article
• The use of glycoprotein IIb/IIIa receptor inhibitors in unstable angina.  Academic Article
• Thrombocytopenia associated with the use of GPIIb/IIIa inhibitors: position paper of the ISTH working group on thrombocytopenia and GPIIb/IIIa inhibitors  Academic Article
• Thrombocytopenia in Patients With an Acute Coronary Syndrome (from the Global Registry of Acute Coronary Events [GRACE])  Academic Article
• Treating Patients With Acute Coronary Syndromes With Aggressive Antiplatelet Therapy (from the Global Registry of Acute Coronary Events)  Academic Article
• Underutilization of clopidogrel and glycoprotein IIb/IIIa inhibitors in non–ST-elevation acute coronary syndrome patients: The Canadian Global Registry of Acute Coronary Events (GRACE) experience  Academic Article
• Unstable angina.  Academic Article
• Unstable angina.  Academic Article
• Use of Heparins in Non-ST-Elevation Acute Coronary Syndromes  Academic Article
• Which antithrombotic to use during PCI?  Academic Article